North America Dialysis Market Value Analysis

Name: North America Dialysis Market Value Analysis | 2025-2030
Creator: Next Move Strategy Consulting
Published: 2026-03-06T19:00:00-05:00
License: https://www.nextmsc.com/privacy-policy

About Report

Download Now

North America Dialysis Market By Modality [Hemodialysis {Hemodialysis Machines (In-center HD, Home HD), Water Treatment Systems (Central water-disinfection units, Point-of-use/portable systems), and Others}, Peritoneal Dialysis (PD Cyclers, Ancillary PD Equipment, and Others)], By End-User (Hospitals, Dialysis Centers, Homecare, and Ambulatory Surgical Centers) – Opportunity Analysis and Industry Forecast, 2025–2030

Download PDF

Speak to Our Analyst

Industry Outlook

The North America Dialysis Market size was valued at USD 34.93 billion in 2024 and is expected to reach USD 39.88 billion by 2025. Looking ahead, the industry is projected to expand significantly, reaching USD 56.22 billion by 2030, registering a CAGR of 7.11% from 2025 to 2030.

The market is experiencing strong growth, primarily fueled by the rising prevalence of chronic kidney disease (CKD) and related health conditions such as diabetes, hypertension, and obesity. These comorbidities are contributing to an increasing number of patients requiring regular renal care. Technological advancements in dialysis, including enhanced hemodialysis and peritoneal dialysis systems, are improving treatment efficacy while ensuring greater patient comfort and safety. Moreover, the growing acceptance of home-based dialysis therapies is transforming care delivery by allowing patients to manage treatments in the comfort of their homes. Supportive healthcare policies, insurance coverage, and the integration of digital health solutions are further facilitating broader access, optimizing treatment efficiency, and improving overall outcomes for patients across North America.

Rising Chronic Kidney Disease and Lifestyle-Related Comorbidities Drive North America Dialysis Market Growth

North America is facing a significant increase in chronic kidney disease (CKD) cases, largely due to the high prevalence of diabetes, hypertension, and obesity. The aging population further contributes to the growing patient base requiring dialysis treatment. As CKD progresses to end-stage renal disease, the demand for both hemodialysis and peritoneal dialysis solutions rises sharply. In response, healthcare providers are investing in modern dialysis technologies, improving infrastructure, and expanding specialized care facilities. Public awareness campaigns on kidney health and early diagnosis initiatives are also facilitating timely treatment. Collectively, these factors are driving robust growth in the dialysis market across North America.

Adoption of Home-Based and Portable Dialysis Solutions Accelerates North America Dialysis Market Expansion

Home-based and portable dialysis therapies are rapidly gaining traction in North America. These solutions allow patients to manage treatments at home, reducing dependence on hospital visits while enhancing convenience and quality of life. Insurance coverage, government initiatives, and patient training programs are supporting the adoption of these therapies. Moreover, digital health tools and remote monitoring systems are enabling clinicians to track patient progress and ensure treatment accuracy, further promoting home-based dialysis. This shift toward patient-centric care models is significantly contributing to market growth across the region.

High Cost of Dialysis Treatment and Equipment Remains a Key Restraint

The substantial cost associated with dialysis treatment and equipment continues to challenge market growth in North America. Establishing dialysis centers requires large investments in advanced machinery, infrastructure, and trained healthcare professionals. Recurring expenses for consumables, maintenance, and patient monitoring further increase the financial burden. Even with insurance and public healthcare support, patients may face significant out-of-pocket costs, particularly for advanced or home-based dialysis systems. These financial constraints can limit accessibility, especially in rural and underserved areas, slowing the overall adoption of modern dialysis solutions.

Technological Innovations and Digital Health Integration Present Significant Opportunities

The integration of digital health solutions and advanced dialysis technologies presents major growth opportunities in North America. Smart dialysis machines, remote monitoring systems, and telehealth platforms are enabling real-time patient tracking, early complication detection, and personalized treatment adjustments. The increasing adoption of home-based dialysis supported by connected technologies is improving patient convenience and reducing hospital dependency. Furthermore, ongoing investments in healthcare infrastructure and the push toward patient-centric care models are driving demand for innovative, intelligent dialysis systems. These developments are expected to expand market reach, enhance treatment outcomes, and strengthen overall growth in the North American dialysis market.

U.S. Holds the Dominant Market Share in the North American Dialysis Market

The U.S. holds a dominant position in the North America dialysis market, driven by a well-established healthcare infrastructure, high prevalence of chronic kidney disease, and widespread adoption of advanced dialysis technologies. The country’s strong focus on patient-centric care, coupled with government initiatives and insurance support, has facilitated broader access to both hospital-based and home-based dialysis therapies. Additionally, continuous innovation in hemodialysis and peritoneal dialysis systems, along with the integration of digital health solutions, has strengthened treatment efficiency and patient outcomes. Leading medical device manufacturers and healthcare providers are concentrated in the U.S., further solidifying its leadership and influence within the North American dialysis landscape.

Mexico to Witness Substantial Growth in the North America Market

Mexico is expected to witness substantial growth in the North America dialysis market, driven by increasing awareness of kidney health, rising prevalence of chronic kidney disease, and expanding access to dialysis treatment across urban and semi-urban regions. The adoption of home-based and portable dialysis therapies is gradually increasing, supported by government initiatives, insurance programs, and training for patients and caregivers. Improvements in healthcare infrastructure and the integration of digital monitoring tools are further enabling effective treatment delivery. Together, these factors are positioning Mexico as a key emerging contributor to the overall growth and development of the dialysis market in North America.

Competitive Landscape

The market players operating in the North America dialysis industry include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun, Asahi Kasei Corporation, Nipro Corporation / Nipro Canada, Becton, Dickinson and Company (BD), Terumo Corporation, W. L. Gore & Associates, Inc., Quanta Dialysis Technologies Ltd, U.S. Renal Care, Inc., Satellite Healthcare, and Others.

North America Dialysis Market Key Segments

By Modality

Hemodialysis (HD)
- Hemodialysis Machines
  - In-center HD
  - Home HD
- Water Treatment Systems
  - Central water-disinfection units
  - Point-of-use/portable systems
- Ancillary/Other HD Equipment
  - UF/ultrafiltration pumps
  - Dialysis chairs/beds
  - Disinfection/sterilization units
  - Monitoring & data-capture hardware
- HD Consumables & Supplies
  - Dialyzers
  - Bloodlines & Tubing Sets
  - Dialysis Fluids / Concentrates
  - Vascular Access Products
  - Other HD Consumables & Accessories
- HD Aftermarket Services
  - Repair & Maintenance
  - Installation & Commissioning
  - Training & Technical Support
Peritoneal Dialysis (PD)
- PD Cyclers / Automated PD Machines
- Ancillary PD Equipment
- PD Consumables & Supplies
  - PD Dialysis Solutions
  - PD Catheters & Access Systems
  - Transfer Sets & Tubing
  - Other PD Supplies / Accessories
- PD Aftermarket Services
  - Repair & Maintenance (Cyclers & Heaters)
  - Installation & Commissioning
  - Training & Technical Support

By End-User

Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers

By Region

U.S.
Canada
Mexico

Key Players

Fresenius Medical Care AG and Co. KGaA
Baxter International Inc.
B. Braun
Asahi Kasei Corporation
Nipro Corporation / Nipro Canada
Becton, Dickinson and Company (BD)
Terumo Corporation
W. L. Gore & Associates, Inc.
Quanta Dialysis Technologies Ltd
U.S. Renal Care, Inc.
Satellite Healthcare
Merit Medical Systems
Teleflex Incorporated
Amsino International, Inc.
Medionics International Inc.

Report Scope and Segmentation

Parameters	Details
Market Size in 2025	USD 39.88 Billion
Revenue Forecast in 2030	USD 56.22 Billion
Growth Rate	CAGR of 7.11% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Billion (USD)
Growth Factors	Growing chronic kidney disease burden drives market demand Expansion of home-based and portable dialysis solutions accelerates adoption
Companies Profiled	15
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

About the Author

Mayurima Roy is a research analyst delivering data-driven insights that support strategic planning and market understanding. She combines analytical rigor with strong content development skills, translating complex information into clear, actionable narratives for diverse audiences. Her work includes structured research, trend tracking, competitive assessment, and insight-led content creation that supports informed decision-making. Curious and detail-oriented by nature, she continually deepens her understanding of evolving markets while pursuing creative interests such as crafting and video creation.

About the Reviewer

Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.

1. 1.1 REPORT DESCRIPTION
2. 1.2 RESEARCH METHODOLOGY
3. 1. 1.2.1 SECONDARY RESEARCH
  2. 1.2.2 DATA ANALYSIS FRAMEWORK
  3. 1.2.3 MARKET SIZE ESTIMATION
  4. 1.2.4 FORECASTING
  5. 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION

1. 2.1. MARKET SNAPSHOT, 2024 - 2030, BILLION USD

1. 3.1 BARGAINING POWER OF SUPPLIERS
2. 3.2 BARGAINING POWER OF BUYERS
3. 3.3 DEGREE OF COMPETITION
4. 3.4 THREAT OF SUBSTITUTE
5. 3.5 THREAT OF NEW ENTRANTS

1. 4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2024

1. 5.1 GROWTH DRIVERS
2. 1. 5.1.1 RISING CHRONIC KIDNEY DISEASE AND LIFESTYLE-RELATED COMORBIDITIES DRIVE NORTH AMERICA DIALYSIS MARKET GROWTH
  2. 5.1.2 ADOPTION OF HOME-BASED AND PORTABLE DIALYSIS SOLUTIONS ACCELERATES NORTH AMERICA DIALYSIS MARKET EXPANSION
3. 5.2 CHALLENGES
4. 1. 5.2.1 HIGH COST OF DIALYSIS TREATMENT AND EQUIPMENT REMAINS A KEY RESTRAINT
5. 5.3 OPPORTUNITIES
6. 1. 5.3.1 TECHNOLOGICAL INNOVATIONS AND DIGITAL HEALTH INTEGRATION PRESENT SIGNIFICANT OPPORTUNITIES

1. 6.1 OVERVIEW
2. 6.2 HEMODIALYSIS (HD)
3. 1. 6.2.1 HEMODIALYSIS (HD) MARKET, BY MODALITY
  2. 1. 6.2.1.1 HEMODIALYSIS MACHINES MARKET, BY COUNTRY
    2. 1. 6.2.1.1.1 IN-CENTER HD
      2. 6.2.1.1.2 HOME HD
    3. 6.2.1.2 WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
    4. 1. 6.2.1.2.1 CENTRAL WATER-DISINFECTION UNITS
      2. 6.2.1.2.2 POINT-OF-USE/PORTABLE SYSTEMS
    5. 6.2.1.3 ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTRY
    6. 1. 6.2.1.3.1 UF/ULTRAFILTRATION PUMPS
      2. 6.2.1.3.2 DIALYSIS CHAIRS/BEDS
      3. 6.2.1.3.3 DISINFECTION/STERILIZATION UNITS
      4. 6.2.1.3.4 MONITORING & DATA-CAPTURE HARDWARE
    7. 6.2.1.4 HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    8. 1. 6.2.1.4.1 DIALYZERS
      2. 6.2.1.4.2 BLOODLINES & TUBING SETS
      3. 6.2.1.4.3 DIALYSIS FLUIDS / CONCENTRATES
      4. 6.2.1.4.4 VASCULAR ACCESS PRODUCTS
      5. 6.2.1.4.5 OTHER HD CONSUMABLES & ACCESSORIES
    9. 6.2.1.5 HD AFTERMARKET SERVICES MARKET, BY COUNTRY
    10. 1. 6.2.1.5.1 REPAIR & MAINTENANCE
      2. 6.2.1.5.2 INSTALLATION & COMMISSIONING
      3. 6.2.1.5.3 TRAINING & TECHNICAL SUPPORT
  3. 6.2.2 HEMODIALYSIS (HD) MARKET, BY COUNTRY
4. 6.3 PERITONEAL DIALYSIS (PD)
5. 1. 6.3.1 PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  2. 1. 6.3.1.1 PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
    2. 6.3.1.2 ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
    3. 6.3.1.3 PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    4. 1. 6.3.1.3.1 PD DIALYSIS SOLUTIONS
      2. 6.3.1.3.2 PD CATHETERS & ACCESS SYSTEMS
      3. 6.3.1.3.3 TRANSFER SETS & TUBING
      4. 6.3.1.3.4 OTHER PD SUPPLIES / ACCESSORIES
    5. 6.3.1.4 PD AFTERMARKET SERVICES MARKET, BY COUNTRY
    6. 1. 6.3.1.4.1 REPAIR & MAINTENANCE (CYCLERS & HEATERS)
      2. 6.3.1.4.2 INSTALLATION & COMMISSIONING
      3. 6.3.1.4.3 TRAINING & TECHNICAL SUPPORT
  3. 6.3.2 PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY

1. 7.1 OVERVIEW
2. 7.2 HOSPITALS
3. 1. 7.2.1 HOSPITALS MARKET, BY COUNTRY
4. 7.3 DIALYSIS CENTERS
5. 1. 7.3.1 DIALYSIS CENTERS MARKET, BY COUNTRY
6. 7.4 HOMECARE
7. 1. 7.4.1 HOMECARE MARKET, BY COUNTRY
8. 7.5 AMBULATORY SURGICAL CENTERS
9. 1. 7.5.1 AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY

1. 8.1 OVERVIEW
2. 8.2 UNITED STATES
3. 1. 8.2.1 UNITED STATES DIALYSIS MARKET, BY MODALITY
  2. 8.2.2 UNITED STATES DIALYSIS MARKET, BY END-USER
4. 8.3 CANADA
5. 1. 8.3.1 CANADA DIALYSIS MARKET, BY MODALITY
  2. 8.3.2 CANADA DIALYSIS MARKET, BY END-USER
6. 8.4 MEXICO
7. 1. 8.4.1 MEXICO DIALYSIS MARKET, BY MODALITY
  2. 8.4.2 MEXICO DIALYSIS MARKET, BY END-USER

1. 9.1 FRESENIUS MEDICAL CARE AG AND CO. KGAA
2. 1. 9.1.1 COMPANY OVERVIEW
  2. 9.1.2 COMPANY SNAPSHOT
  3. 9.1.3 OPERATING BUSINESS SEGMENTS
  4. 9.1.4 PRODUCT PORTFOLIO
  5. 9.1.5 BUSINESS PERFORMANCE
  6. 9.1.6 BUSINESS SEGMENTS
  7. 9.1.7 GEOGRAPHIC SEGMENTS
  8. 9.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.1.9 PRIMARY MARKET COMPETITORS
3. 9.2 BAXTER INTERNATIONAL INC.
4. 1. 9.2.1 COMPANY OVERVIEW
  2. 9.2.2 COMPANY SNAPSHOT
  3. 9.2.3 OPERATING BUSINESS SEGMENTS
  4. 9.2.4 PRODUCT PORTFOLIO
  5. 9.2.5 BUSINESS PERFORMANCE
  6. 9.2.6 BUSINESS SEGMENTS
  7. 9.2.7 GEOGRAPHIC SEGMENTS
  8. 9.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.2.9 PRIMARY MARKET COMPETITORS
5. 9.3 B. BRAUN
6. 1. 9.3.1 COMPANY OVERVIEW
  2. 9.3.2 COMPANY SNAPSHOT
  3. 9.3.3 OPERATING BUSINESS SEGMENTS
  4. 9.3.4 PRODUCT PORTFOLIO
  5. 9.3.5 BUSINESS PERFORMANCE
  6. 9.3.6 BUSINESS SEGMENTS
  7. 9.3.7 GEOGRAPHIC SEGMENTS
  8. 9.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.3.9 PRIMARY MARKET COMPETITORS
7. 9.4 ASAHI KASEI CORPORATION
8. 1. 9.4.1 COMPANY OVERVIEW
  2. 9.4.2 COMPANY SNAPSHOT
  3. 9.4.3 OPERATING BUSINESS SEGMENTS
  4. 9.4.4 PRODUCT PORTFOLIO
  5. 9.4.5 BUSINESS PERFORMANCE
  6. 9.4.6 BUSINESS SEGMENTS
  7. 9.4.7 GEOGRAPHIC SEGMENTS
  8. 9.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.4.9 PRIMARY MARKET COMPETITORS
9. 9.5 NIPRO CORPORATION / NIPRO CANADA
10. 1. 9.5.1 COMPANY OVERVIEW
  2. 9.5.2 COMPANY SNAPSHOT
  3. 9.5.3 OPERATING BUSINESS SEGMENTS
  4. 9.5.4 PRODUCT PORTFOLIO
  5. 9.5.5 BUSINESS PERFORMANCE
  6. 9.5.6 BUSINESS SEGMENTS
  7. 9.5.7 GEOGRAPHIC SEGMENTS
  8. 9.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.5.9 PRIMARY MARKET COMPETITORS
11. 9.6 BECTON, DICKINSON AND COMPANY (BD)
12. 1. 9.6.1 COMPANY OVERVIEW
  2. 9.6.2 COMPANY SNAPSHOT
  3. 9.6.3 OPERATING BUSINESS SEGMENTS
  4. 9.6.4 PRODUCT PORTFOLIO
  5. 9.6.5 BUSINESS PERFORMANCE
  6. 9.6.6 BUSINESS SEGMENTS
  7. 9.6.7 GEOGRAPHIC SEGMENTS
  8. 9.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.6.9 PRIMARY MARKET COMPETITORS
13. 9.7 TERUMO CORPORATION
14. 1. 9.7.1 COMPANY OVERVIEW
  2. 9.7.2 COMPANY SNAPSHOT
  3. 9.7.3 OPERATING BUSINESS SEGMENTS
  4. 9.7.4 PRODUCT PORTFOLIO
  5. 9.7.5 BUSINESS PERFORMANCE
  6. 9.7.6 BUSINESS SEGMENTS
  7. 9.7.7 GEOGRAPHIC SEGMENTS
  8. 9.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.7.9 PRIMARY MARKET COMPETITORS
15. 9.8 W. L. GORE AND ASSOCIATES, INC.
16. 1. 9.8.1 COMPANY OVERVIEW
  2. 9.8.2 COMPANY SNAPSHOT
  3. 9.8.3 OPERATING BUSINESS SEGMENTS
  4. 9.8.4 PRODUCT PORTFOLIO
  5. 9.8.5 BUSINESS PERFORMANCE
  6. 9.8.6 BUSINESS SEGMENTS
  7. 9.8.7 GEOGRAPHIC SEGMENTS
  8. 9.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.8.9 PRIMARY MARKET COMPETITORS
17. 9.9 QUANTA DIALYSIS TECHNOLOGIES LTD
18. 1. 9.9.1 COMPANY OVERVIEW
  2. 9.9.2 COMPANY SNAPSHOT
  3. 9.9.3 OPERATING BUSINESS SEGMENTS
  4. 9.9.4 PRODUCT PORTFOLIO
  5. 9.9.5 BUSINESS PERFORMANCE
  6. 9.9.6 BUSINESS SEGMENTS
  7. 9.9.7 GEOGRAPHIC SEGMENTS
  8. 9.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.9.9 PRIMARY MARKET COMPETITORS
19. 9.10 U.S. RENAL CARE, INC.
20. 1. 9.10.1 COMPANY OVERVIEW
  2. 9.10.2 COMPANY SNAPSHOT
  3. 9.10.3 OPERATING BUSINESS SEGMENTS
  4. 9.10.4 PRODUCT PORTFOLIO
  5. 9.10.5 BUSINESS PERFORMANCE
  6. 9.10.6 BUSINESS SEGMENTS
  7. 9.10.7 GEOGRAPHIC SEGMENTS
  8. 9.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.10.9 PRIMARY MARKET COMPETITORS
21. 9.11 SATELLITE HEALTHCARE
22. 1. 9.11.1 COMPANY OVERVIEW
  2. 9.11.2 COMPANY SNAPSHOT
  3. 9.11.3 OPERATING BUSINESS SEGMENTS
  4. 9.11.4 PRODUCT PORTFOLIO
  5. 9.11.5 BUSINESS PERFORMANCE
  6. 9.11.6 BUSINESS SEGMENTS
  7. 9.11.7 GEOGRAPHIC SEGMENTS
  8. 9.11.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.11.9 PRIMARY MARKET COMPETITORS
23. 9.12 MERIT MEDICAL SYSTEMS
24. 1. 9.12.1 COMPANY OVERVIEW
  2. 9.12.2 COMPANY SNAPSHOT
  3. 9.12.3 OPERATING BUSINESS SEGMENTS
  4. 9.12.4 PRODUCT PORTFOLIO
  5. 9.12.5 BUSINESS PERFORMANCE
  6. 9.12.6 BUSINESS SEGMENTS
  7. 9.12.7 GEOGRAPHIC SEGMENTS
  8. 9.12.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.12.9 PRIMARY MARKET COMPETITORS
25. 9.13 TELEFLEX INCORPORATED
26. 1. 9.13.1 COMPANY OVERVIEW
  2. 9.13.2 COMPANY SNAPSHOT
  3. 9.13.3 OPERATING BUSINESS SEGMENTS
  4. 9.13.4 PRODUCT PORTFOLIO
  5. 9.13.5 BUSINESS PERFORMANCE
  6. 9.13.6 BUSINESS SEGMENTS
  7. 9.13.7 GEOGRAPHIC SEGMENTS
  8. 9.13.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.13.9 PRIMARY MARKET COMPETITORS
27. 9.14 AMSINO INTERNATIONAL, INC.
28. 1. 9.14.1 COMPANY OVERVIEW
  2. 9.14.2 COMPANY SNAPSHOT
  3. 9.14.3 OPERATING BUSINESS SEGMENTS
  4. 9.14.4 PRODUCT PORTFOLIO
  5. 9.14.5 BUSINESS PERFORMANCE
  6. 9.14.6 BUSINESS SEGMENTS
  7. 9.14.7 GEOGRAPHIC SEGMENTS
  8. 9.14.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.14.9 PRIMARY MARKET COMPETITORS
29. 9.15 MEDIONICS INTERNATIONAL INC.
30. 1. 9.15.1 COMPANY OVERVIEW
  2. 9.15.2 COMPANY SNAPSHOT
  3. 9.15.3 OPERATING BUSINESS SEGMENTS
  4. 9.15.4 PRODUCT PORTFOLIO
  5. 9.15.5 BUSINESS PERFORMANCE
  6. 9.15.6 BUSINESS SEGMENTS
  7. 9.15.7 GEOGRAPHIC SEGMENTS
  8. 9.15.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.15.9 PRIMARY MARKET COMPETITORS

TABLE 1. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 2. HEMODIALYSIS MACHINES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 3. WATER TREATMENT SYSTEMS, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 4. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 5. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 6. HD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 7. HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 8. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 9. ANCILLARY PD EQUIPMENT, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 10. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 11. PD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 12. PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 13. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 14. HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 15. DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 16. HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 17. AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 18. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 19. UNITED STATES DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 20. UNITED STATES DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 21. CANADA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 22. CANADA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 23. MEXICO DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 24. MEXICO DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 25. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 26. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS
TABLE 27. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 28. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 29. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 30. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY
TABLE 31. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 32. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS
TABLE 33. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 34. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 35. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 36. BAXTER INTERNATIONAL INC.: KEY STRATERGY
TABLE 37. B. BRAUN: COMPANY SNAPSHOT
TABLE 38. B. BRAUN: OPERATING BUSINESS SEGMENTS
TABLE 39. B. BRAUN: PRODUCT PORTFOLIO
TABLE 40. B. BRAUN: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 41. B. BRAUN: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 42. B. BRAUN: KEY STRATERGY
TABLE 43. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
TABLE 44. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 45. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
TABLE 46. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 47. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 48. ASAHI KASEI CORPORATION: KEY STRATERGY
TABLE 49. NIPRO CORPORATION / NIPRO CANADA: COMPANY SNAPSHOT
TABLE 50. NIPRO CORPORATION / NIPRO CANADA: OPERATING BUSINESS SEGMENTS
TABLE 51. NIPRO CORPORATION / NIPRO CANADA: PRODUCT PORTFOLIO
TABLE 52. NIPRO CORPORATION / NIPRO CANADA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 53. NIPRO CORPORATION / NIPRO CANADA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 54. NIPRO CORPORATION / NIPRO CANADA: KEY STRATERGY
TABLE 55. BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
TABLE 56. BECTON, DICKINSON AND COMPANY (BD): OPERATING BUSINESS SEGMENTS
TABLE 57. BECTON, DICKINSON AND COMPANY (BD): PRODUCT PORTFOLIO
TABLE 58. BECTON, DICKINSON AND COMPANY (BD): SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 59. BECTON, DICKINSON AND COMPANY (BD): SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 60. BECTON, DICKINSON AND COMPANY (BD): KEY STRATERGY
TABLE 61. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 62. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 63. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 64. TERUMO CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 65. TERUMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 66. TERUMO CORPORATION: KEY STRATERGY
TABLE 67. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 68. W. L. GORE AND ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 69. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
TABLE 70. W. L. GORE AND ASSOCIATES, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 71. W. L. GORE AND ASSOCIATES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 72. W. L. GORE AND ASSOCIATES, INC.: KEY STRATERGY
TABLE 73. QUANTA DIALYSIS TECHNOLOGIES LTD: COMPANY SNAPSHOT
TABLE 74. QUANTA DIALYSIS TECHNOLOGIES LTD: OPERATING BUSINESS SEGMENTS
TABLE 75. QUANTA DIALYSIS TECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 76. QUANTA DIALYSIS TECHNOLOGIES LTD: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 77. QUANTA DIALYSIS TECHNOLOGIES LTD: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 78. QUANTA DIALYSIS TECHNOLOGIES LTD: KEY STRATERGY
TABLE 79. U.S. RENAL CARE, INC.: COMPANY SNAPSHOT
TABLE 80. U.S. RENAL CARE, INC.: OPERATING BUSINESS SEGMENTS
TABLE 81. U.S. RENAL CARE, INC.: PRODUCT PORTFOLIO
TABLE 82. U.S. RENAL CARE, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 83. U.S. RENAL CARE, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 84. U.S. RENAL CARE, INC.: KEY STRATERGY
TABLE 85. SATELLITE HEALTHCARE: COMPANY SNAPSHOT
TABLE 86. SATELLITE HEALTHCARE: OPERATING BUSINESS SEGMENTS
TABLE 87. SATELLITE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 88. SATELLITE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 89. SATELLITE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 90. SATELLITE HEALTHCARE: KEY STRATERGY
TABLE 91. MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 92. MERIT MEDICAL SYSTEMS: OPERATING BUSINESS SEGMENTS
TABLE 93. MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 94. MERIT MEDICAL SYSTEMS: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 95. MERIT MEDICAL SYSTEMS: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 96. MERIT MEDICAL SYSTEMS: KEY STRATERGY
TABLE 97. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 98. TELEFLEX INCORPORATED: OPERATING BUSINESS SEGMENTS
TABLE 99. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 100. TELEFLEX INCORPORATED: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 101. TELEFLEX INCORPORATED: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 102. TELEFLEX INCORPORATED: KEY STRATERGY
TABLE 103. AMSINO INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 104. AMSINO INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS
TABLE 105. AMSINO INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 106. AMSINO INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 107. AMSINO INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 108. AMSINO INTERNATIONAL, INC.: KEY STRATERGY
TABLE 109. MEDIONICS INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 110. MEDIONICS INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS
TABLE 111. MEDIONICS INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 112. MEDIONICS INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 113. MEDIONICS INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 114. MEDIONICS INTERNATIONAL INC.: KEY STRATERGY

FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
FIGURE 7. HEMODIALYSIS MACHINES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 8. WATER TREATMENT SYSTEMS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 9. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 10. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 11. HD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 12. HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 13. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 14. ANCILLARY PD EQUIPMENT, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 15. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 16. PD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 17. PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 18. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
FIGURE 19. HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 20. DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 21. HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 22. AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 23. NORTH AMERICA NORTH AMERICA DIALYSIS MARKET VALUE, BY REGION 2024-2030, (BILLION USD)
FIGURE 24. UNITED STATES DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 25. UNITED STATES DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 26. CANADA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 27. CANADA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 28. MEXICO DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 29. MEXICO DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 30. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2022-2024)
FIGURE 31. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS
FIGURE 32. BAXTER INTERNATIONAL INC.: NET SALES, (2022-2024)
FIGURE 33. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS
FIGURE 34. B. BRAUN: NET SALES, (2022-2024)
FIGURE 35. B. BRAUN: PRIMARY MARKET COMPETITORS
FIGURE 36. ASAHI KASEI CORPORATION: NET SALES, (2022-2024)
FIGURE 37. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 38. NIPRO CORPORATION / NIPRO CANADA: NET SALES, (2022-2024)
FIGURE 39. NIPRO CORPORATION / NIPRO CANADA: PRIMARY MARKET COMPETITORS
FIGURE 40. BECTON, DICKINSON AND COMPANY (BD): NET SALES, (2022-2024)
FIGURE 41. BECTON, DICKINSON AND COMPANY (BD): PRIMARY MARKET COMPETITORS
FIGURE 42. TERUMO CORPORATION: NET SALES, (2022-2024)
FIGURE 43. TERUMO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 44. W. L. GORE AND ASSOCIATES, INC.: NET SALES, (2022-2024)
FIGURE 45. W. L. GORE AND ASSOCIATES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 46. QUANTA DIALYSIS TECHNOLOGIES LTD: NET SALES, (2022-2024)
FIGURE 47. QUANTA DIALYSIS TECHNOLOGIES LTD: PRIMARY MARKET COMPETITORS
FIGURE 48. U.S. RENAL CARE, INC.: NET SALES, (2022-2024)
FIGURE 49. U.S. RENAL CARE, INC.: PRIMARY MARKET COMPETITORS
FIGURE 50. SATELLITE HEALTHCARE: NET SALES, (2022-2024)
FIGURE 51. SATELLITE HEALTHCARE: PRIMARY MARKET COMPETITORS
FIGURE 52. MERIT MEDICAL SYSTEMS: NET SALES, (2022-2024)
FIGURE 53. MERIT MEDICAL SYSTEMS: PRIMARY MARKET COMPETITORS
FIGURE 54. TELEFLEX INCORPORATED: NET SALES, (2022-2024)
FIGURE 55. TELEFLEX INCORPORATED: PRIMARY MARKET COMPETITORS
FIGURE 56. AMSINO INTERNATIONAL, INC.: NET SALES, (2022-2024)
FIGURE 57. AMSINO INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS
FIGURE 58. MEDIONICS INTERNATIONAL INC.: NET SALES, (2022-2024)
FIGURE 59. MEDIONICS INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

SWOT Analysis

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.

Download Free Sample

Full Name *

Please Enter Full Name

Business Email Id *

Please Enter Valid Email ID

Phone Number *

Please enter Country Code and Phone No

Message

Please enter message

Yes, I have read the Privacy Policy

Frequently Asked Questions

As per NMSC, the North America dialysis market was valued at USD 39.88 billion in 2025.

According to projections from Next Move Strategy Consulting, the North America dialysis market growth is anticipated to reach USD 56.22 billion by 2030.

Portable machines, remote monitoring systems, and smart connected dialysis devices improve treatment efficiency and patient outcomes.

Yes, insurance programs, public healthcare initiatives, and reimbursement schemes support home-based therapies and access to advanced dialysis treatments.

Home dialysis allows patients to manage treatment at home, reducing hospital visits and improving convenience and quality of life.

Purchase Options Flash
sale

Multi User

$3,917 $5595

Single User

$3,217 $4595

Enterprise

$5,317 $7595

Datapack

$1,817 $2595

Download Sample

Inquire Before Buying